Kinetin expands in Asia
This article was originally published in The Rose Sheet
Executive Summary
Kinetin-based skin care products will be sold through physicians in Taiwan and Hong Kong starting in the second half of 2003 under licensing agreement between Senetek and Taiwan-based Panion & BF Biotech, Napa, Calif. firm states March 12. Agreement with cosmeceuticals marketer also calls for development of additional proprietary Kinetin-based products, Senetek says. Panion & BF Biotech is "invaluable partner" in expanding ingredient in Asia, Senetek adds, noting expansion into China, Thailand, Singapore, Malaysia and Vietnam also are under review. Senetek signed deal last year with Rohto Pharmaceutical to market Kinetin products in Japanese drug store channel (1"The Rose Sheet" July 1, 2002, In Brief)...
You may also be interested in...
Kinetin in Japan
Senetek signs licensing agreement with Rohto Pharmaceutical for marketing of products containing Kinetin in the Japanese drug store channel, Napa, Calif. firm says. Senetek also in licensing negotiations with a Japanese cosmetics company to distribute products containing Kinetin in prestige sector under three "well-known" trademarks, firm adds. Revlon markets a line of Kinetin-containing products under the Almay brand, and The Body Shop also sells a Kinetin skin care line (1"The Rose Sheet" March 19, 2001, p. 7 and 2"The Rose Sheet" Feb 19, 2001, p. 6)...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.